Pan, J
Yang, J F
Deng, B P
Zhao, X J
Zhang, X
Lin, Y H
Wu, Y N
Deng, Z L
Zhang, Y L
Liu, S H
Wu, T
Lu, P H
Lu, D P
Chang, A H
Tong, C R
Article History
Received: 23 January 2017
Revised: 25 April 2017
Accepted: 4 May 2017
First Online: 15 May 2017
Competing interests
: AHC is also a founding member of Shanghai YaKe Biotechnology Ltd., a biotechnology company focused on research and development of tumor cell immunotherapy. YZ and SL are also employees of Shanghai YaKe Biotechnoloy Ltd. The remaining authors declare no conflict of interest.